Erythrocytes Display Metabolic Changes in High-Altitude Polycythemia.

Qile, Muge, Qiying Xu, Yi Ye, Huifang Liu, Drolma Gomchok, Juanli Liu, Tana Wuren, and Ri-Li Ge. Erythrocytes display metabolic changes in high-altitude polycythemia. High Alt Med Biol. 00:000-000, 2023. Background: Sphingosine-1-phosphate (S1P) levels are increased after acute exposure to high altitude; however, whether this effect is observed in chronic high-altitude hypoxia is unknown. Methods: We studied erythrocyte S1P levels in 13 subjects with high-altitude polycythemia (HAPC) and 13 control subjects and also used a mouse model of HAPC. HAPC subjects lived in Maduo (4,300 m altitude) for 10 years, whereas control subjects lived permanently in Xining (2,260 m). The mouse model of HAPC was established by stimulating an altitude of 5,000 m in a hypobaric chamber for 30 days. Hematology and S1P, CD73, 2,3-bisphosphoglycerate (2,3-BPG), and reticulocyte levels were measured. Results: The hemoglobin concentration and number of red blood cells were significantly elevated in human and mouse HAPC groups. Blood S1P levels in HAPC subjects and mice were higher than those in control groups (p < 0.05 and p < 0.001, respectively). 2,3-BPG and CD73 levels in HAPC subjects were significantly higher than those in control subjects (p < 0.05). No significant changes in reticulocyte levels were observed. Conclusions: The critical altitude-induced metabolic changes such as S1P retained high levels even after prolonged exposure, and it may inspire future research into therapeutic strategies for hypoxia-associated illnesses.

[1]  M. Galbraith,et al.  Sphingosine 1-phosphate has a negative effect on RBC storage quality , 2022, Blood advances.

[2]  Tushar Sehgal,et al.  Reticulocyte count: a simple test but tricky interpretation! , 2021, The Pan African medical journal.

[3]  K. He,et al.  Macitentan attenuates chronic mountain sickness in rats by regulating arginine and purine metabolism. , 2020, Journal of proteome research.

[4]  Natasha T. Snider,et al.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73). , 2019, American journal of physiology. Cell physiology.

[5]  Mostafa H. Ahmed,et al.  Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease , 2016, Scientific Reports.

[6]  M. Gladwin,et al.  AltitudeOmics: Red Blood Cell Metabolic Adaptation to High Altitude Hypoxia. , 2016, Journal of proteome research.

[7]  A. Subudhi,et al.  Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia , 2016, Nature Communications.

[8]  Raffaella Casadei,et al.  An estimation of the number of cells in the human body , 2013, Annals of human biology.

[9]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[10]  M. Gräler,et al.  Erythrocytes store and release sphingosine 1‐phosphate in blood , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  F. Léon-Velarde,et al.  Consensus statement on chronic and subacute high altitude diseases. , 2005, High altitude medicine & biology.

[12]  F. Léon-Velarde,et al.  Chronic mountain sickness: recent studies of the relationship between hemoglobin concentration and oxygen transport. , 2004, High altitude medicine & biology.

[13]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[14]  H. Rusko,et al.  EPO, red cells, and serum transferrin receptor in continuous and intermittent hypoxia. , 2000, Medicine and science in sports and exercise.

[15]  W. Schobersberger,et al.  Unchanged in vivo P50 at high altitude despite decreased erythrocyte age and elevated 2,3-diphosphoglycerate. , 1990, Journal of applied physiology.

[16]  C. Lenfant,et al.  Shift of the O2-Hb dissociation curve at altitude: mechanism and effect. , 1971, Journal of applied physiology.